Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing the Rate and Duration of Re-ADMISsions Among Patients With Unipolar Disorder and Bipolar Disorder Using Smartphone-based Monitoring and Treatment - The RADMIS Trials

NCT03033420 is registered in ClinicalTrials.gov with Psychiatric Centre Rigshospitalet as lead sponsor.

NCT NCT03033420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03033420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing the Rate and Duration of Re-ADMISsions Among Patients With Unipolar Disorder and Bipolar Disorder Using Smartphone-based Monitoring and Treatment - The RADMIS Trials
Lead sponsor
Psychiatric Centre Rigshospitalet
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2017
Completion date
May 1, 2021
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

affective disorders, bipolar disorder, unipolar depression